Clinical Trials
2 trialsNCT04617522 2026-02-11
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment
Gilead Sciences
Phase 1 Recruiting
NCT01452295 2013-12-04
Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion
Vital Therapies, Inc.
Phase 2/3 Withdrawn